合同会社SOLA Biosciences Japan、AMED「創薬ベンチャーエコシステム強化事業」に採択

SOLA Biosciences Japan Receives AMED Grant to Advance SOL-257, Innovative Gene Therapy Aiming to Restore TDP-43 Function for ALS Patients